Has Melissa Kulp received payments from drug or device companies?

Yes. Drug and device makers reported $2,836 in general payments to Melissa Kulp across 105 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Melissa Kulp did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Melissa Kulp come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Melissa Kulp

Family · Jerseyville, ILNPI 1003232489

Payments from drug & device makers

$2,836in general payments, 2019–2025

Across 105 payments — averaging $27.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$939
Amgen$330
Boston Scientific$302
Medtronic$302
Collegium Pharmaceutical, Inc.$255
Johnson & Johnson$151
plus $557 from 11 others

What the payments were for

Consulting fees$1756%
Food & beverage$2,66194%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	38	$939
Amgen	11	$330
Boston Scientific	5	$302
Medtronic	5	$302
Collegium Pharmaceutical, Inc.	13	$255
Johnson & Johnson	8	$151
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	6	$134
Vertos Medical, Inc.	2	$116
Exact Sciences	5	$94
Lilly USA, LLC	2	$41
Almatica Pharma LLC	2	$40
Alkermes, Inc.	2	$33
Novo Nordisk	2	$32
Biogen	1	$22
AstraZeneca	1	$16
Pfizer	1	$15
Gilead	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,836 in reported general payments places this provider in the 85th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OzempicSemaglutide	36	$61,100
JardianceEmpagliflozin	30	$49,240
Xtampza ErOxycodone Myristate	42	$26,345
FarxigaDapagliflozin Propanediol	19	$17,805
LinzessLinaclotide	19	$12,812
EliquisApixaban	13	$11,146
Breztri AerosphereBudesonide/Glycopyr/Formoterol	17	$10,517
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	15	$9,862
XareltoRivaroxaban	14	$8,204
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	175	$4,459
Buprenorphine	24	$4,235
Pregabalin	127	$4,064
Fluticasone-SalmeterolFluticasone Propion/Salmeterol	21	$2,008
Duloxetine Hcl	70	$1,888
Gabapentin	82	$1,438

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Novo NordiskOzempic	$32	$61,10036 claims
AstraZenecaFarxiga, Breztri Aerosphere	$16	$28,32236 claims
Collegium Pharmaceutical, Inc.Xtampza Er	$255	$26,34542 claims
AbbVieLinzess	$939	$12,81219 claims
PfizerEliquis	$15	$11,14613 claims
Johnson & JohnsonXarelto	$151	$8,20414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,941 family providers in Illinois.

Other family in Jerseyville

Ruth CarricoChicago$582K
Aleksandra BielawiecBarrington$373K
Erin SieberNaperville$334K
Jamie BroganChicago$282K
Ashley NoethGlen Carbon$271K
Marita KametasChicago$259K
Shammona ClarkChicago$247K
Amanda McKeeMount Vernon$242K
Brooke KennardBloomington$208K
Amy BrownellElk Grove Village$202K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →